What is the current annual EBITDA of COO?

As of today, COO annual EBITDA is $1.11B

What is 1-year change in COO annual EBITDA?

COO annual EBITDA is down -1.21% year-over-year

What is 3-year change in COO annual EBITDA?

COO annual EBITDA is up +18.99% over the past 3 years

How far is COO annual EBITDA from its all-time high?

COO annual EBITDA is currently -1.21% below its historical high of $1.12B set on October 31, 2024

How does COO annual EBITDA rank versus sector peers?

COO annual EBITDA is higher than 93.38% of companies in Healthcare sector

When is COO next annual earnings release?

The next annual earnings release for COO is on December 10, 2026

What is the current quarterly EBITDA of COO?

As of today, COO quarterly EBITDA is $317.00M

What is COO quarterly EBITDA most recent change?

COO quarterly EBITDA was down -5.65% on July 31, 2026

What is 1-year change in COO quarterly EBITDA?

COO quarterly EBITDA is up +16.93% year-over-year

How far is COO quarterly EBITDA from its all-time high?

COO quarterly EBITDA is currently -5.65% below its historical high of $336.00M set on April 30, 2026

How does COO quarterly EBITDA rank versus sector peers?

COO quarterly EBITDA is higher than 93.18% of companies in Healthcare sector

When is COO next earnings release?

The next earnings release for COO is on December 10, 2026

What is the current TTM EBITDA of COO?

As of today, COO TTM EBITDA is $1.20B

What is COO TTM EBITDA most recent change?

COO TTM EBITDA was up +3.98% on July 31, 2026

What is 1-year change in COO TTM EBITDA?

COO TTM EBITDA is up +8.03% year-over-year

How far is COO TTM EBITDA from its all-time high?

COO TTM EBITDA is currently at its all-time high

How does COO TTM EBITDA rank versus sector peers?

COO TTM EBITDA is higher than 93.46% of companies in Healthcare sector

When is COO next earnings release?

The next earnings release for COO is on December 10, 2026

COO EBITDA History & Chart Since 1982

Annual EBITDA

$1.11B$13.60M-1.21%

October 31, 2025

Summary

Current Value: As of today, COO annual EBITDA is $1.11B, down -1.21% on October 31, 2025
Historical Performance: COO annual EBITDA is up +18.99% over the past 3 years, up +68.15% over the past 5 years
All-Time High Comparison: COO annual EBITDA is currently -1.21% below its historical high of $1.12B set on October 31, 2024
3-Year Low Comparison: COO annual EBITDA is +21.66% above its 3-year low of $909.00M reached on October 31, 2023
Sector Comparison: COO annual EBITDA is higher than 93.38% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

COO Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Oct 31, 25	$1.11B	-1.2%	+19.0%	+68.2%	+264.7%
Quarterly EBITDA	Jul 31, 26	$317.00M	+16.9%	+28.8%	+21.0%	+386.1%
TTM EBITDA	Jul 31, 26	$1.20B	+8.0%	+32.5%	+30.1%	+291.0%
Price	Sep 29, 26	$56.63	-16.3%	-28.8%	-46.4%	+185.3%
PE Ratio	Sep 29, 26	19.33	-42.0%	-66.4%	+168.5%	-14.8%
Annual Revenue	Oct 31, 25	$4.09B	+5.1%	+23.7%	+68.3%	+251.6%
Annual EPS	Oct 31, 25	$1.87	-4.2%	-3.4%	+56.0%	+208.6%
	Oct 31, 25	$745.20M	+5.6%	+35.2%	+120.4%	+256.1%
Annual Net Income	Oct 31, 25	$374.90M	-4.4%	-2.8%	+57.3%	+232.3%

EBITDA Highs

COO Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.12B	Oct 31, 24	-1.2%
5Y	$1.12B	Oct 31, 24	-1.2%
All	$1.12B	Oct 31, 24	-1.2%

EBITDA Lows

COO Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$909.00M	Oct 31, 23	+21.7%
5Y	$657.70M	N/A	+68.2%
All	-$28.19M	Oct 31, 91	+4023.7%

EBITDA History

Year	Value	Change
2025	$1.11B	-1.2%
2024	$1.12B	+23.2%
2023	$909.00M	-2.2%
2022	$929.40M	+7.3%
2021	$866.20M	+31.7%
2020	$657.70M	-22.6%
2019	$849.60M	+10.1%
2018	$771.60M	+15.2%
2017	$670.00M	+9.8%
2016	$610.20M	+10.7%
2015	$551.07M	+14.0%
2014	$483.59M	+6.9%
2013	$452.36M	+13.2%
2012	$399.51M	+23.3%
2011	$324.01M	+6.8%
2010	$303.24M	+23.1%
2009	$246.35M	-0.8%
2008	$248.25M	+32.6%
2007	$187.17M	-2.3%
2006	$191.63M	+235.6%
2005	$57.10M	-56.9%
2004	$132.40M	+22.9%

Year	Value	Change
2003	$107.77M	+37.6%
2002	$78.34M	+19.2%
2001	$65.75M	+18.2%
2000	$55.60M	+17.7%
1999	$47.25M	+24.0%
1998	$38.12M	+25.2%
1997	$30.46M	+47.0%
1996	$20.72M	+57.2%
1995	$13.18M	+208.9%
1994	$4.27M	+124.2%
1993	-$17.61M	+4.9%
1992	-$18.51M	+34.3%
1991	-$28.19M	-136.4%
1990	-$11.92M	-2,358.3%
1989	$528.00K	-99.2%
1988	$64.25M	+115.6%
1987	$29.81M	-50.5%
1986	$60.27M	-6.9%
1985	$64.73M	+41.8%
1984	$45.65M	+34.4%
1983	$33.97M	+49.8%
1982	$22.67M	-

FAQ

What is the current annual EBITDA of COO?: As of today, COO annual EBITDA is $1.11B
What is 1-year change in COO annual EBITDA?: COO annual EBITDA is down -1.21% year-over-year
What is 3-year change in COO annual EBITDA?: COO annual EBITDA is up +18.99% over the past 3 years
How far is COO annual EBITDA from its all-time high?: COO annual EBITDA is currently -1.21% below its historical high of $1.12B set on October 31, 2024
How does COO annual EBITDA rank versus sector peers?: COO annual EBITDA is higher than 93.38% of companies in Healthcare sector
When is COO next annual earnings release?: The next annual earnings release for COO is on December 10, 2026

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$317.00M$19.00M-5.65%

July 31, 2026

Summary

Current Value: As of today, COO quarterly EBITDA is $317.00M, down -5.65% on July 31, 2026
Historical Performance: COO quarterly EBITDA is up +16.93% year-over-year, up +28.81% over the past 3 years
All-Time High Comparison: COO quarterly EBITDA is currently -5.65% below its historical high of $336.00M set on April 30, 2026
3-Year Low Comparison: COO quarterly EBITDA is +32.75% above its 3-year low of $238.80M reached on October 31, 2025
Sector Comparison: COO quarterly EBITDA is higher than 93.18% of companies in Healthcare sector

Performance

COO Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jul 31, 26	$317.00M	-5.7%	+16.9%	+28.8%	+21.0%
Annual EBITDA	Oct 31, 25	$1.11B	–	-1.2%	+19.0%	+68.2%
TTM EBITDA	Jul 31, 26	$1.20B	+4.0%	+8.0%	+32.5%	+30.1%
Price	Sep 29, 26	$56.63	-20.7%	-16.3%	-28.8%	-46.4%
PE Ratio	Sep 29, 26	19.33	-67.9%	-42.0%	-66.4%	+168.5%
Quarterly Revenue	Jul 31, 26	$1.07B	-1.4%	+0.6%	+14.6%	+39.7%
Quarterly EPS	Jul 31, 26	$2.24	+660.1%	+355.3%	+423.6%	-27.6%
	Jul 31, 26	$222.40M	-7.6%	+26.6%	+46.7%	+118.5%
Quarterly Net Income	Jul 31, 26	$432.80M	+655.6%	+340.3%	+407.4%	-29.7%

Quarterly EBITDA Highs

COO Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$336.00M	Apr 30, 26	-5.7%
3Y	$336.00M	Apr 30, 26	-5.7%
5Y	$336.00M	Apr 30, 26	-5.7%
All	$336.00M	Apr 30, 26	-5.7%

Quarterly EBITDA Lows

COO Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$238.80M	Oct 31, 25	+32.8%
3Y	$238.80M	Oct 31, 25	+32.8%
5Y	$187.10M	Apr 30, 23	+69.4%
All	-$428.30M	Oct 31, 88	+174.0%

Quarterly EBITDA History

Month	Value	Change
Jul 2026	$317.00M	-5.7%
Apr 2026	$336.00M	+9.0%
Jan 2026	$308.30M	+29.1%
Oct 2025	$238.80M	-11.9%
Jul 2025	$271.10M	-2.3%
Apr 2025	$277.40M	+1.6%
Jan 2025	$273.00M	-5.7%
Oct 2024	$289.40M	+2.8%
Jul 2024	$281.50M	+8.3%
Apr 2024	$260.00M	+4.0%
Jan 2024	$249.90M	-6.9%
Oct 2023	$268.40M	+9.1%
Jul 2023	$246.10M	+31.5%
Apr 2023	$187.10M	-21.8%
Jan 2023	$239.20M	+2.4%
Oct 2022	$233.50M	+4.9%
Jul 2022	$222.60M	-7.2%
Apr 2022	$240.00M	+6.6%
Jan 2022	$225.10M	+3.5%
Oct 2021	$217.40M	-17.0%
Jul 2021	$261.90M	-2.1%
Apr 2021	$267.50M	+25.9%
Jan 2021	$212.50M	+17.8%
Oct 2020	$180.40M	+19.6%
Jul 2020	$150.80M	+26.9%
Apr 2020	$118.80M	-38.8%
Jan 2020	$194.20M	-14.4%
Oct 2019	$227.00M	+2.9%
Jul 2019	$220.50M	+5.6%
Apr 2019	$208.80M	+7.2%
Jan 2019	$194.70M	-5.7%
Oct 2018	$206.40M	+2.0%
Jul 2018	$202.40M	+7.7%
Apr 2018	$187.90M	+6.6%
Jan 2018	$176.20M	+2.9%
Oct 2017	$171.30M	0.0%
Jul 2017	$171.30M	-4.9%
Apr 2017	$180.20M	+25.0%
Jan 2017	$144.20M	+18.7%
Oct 2016	$121.53M	-20.1%
Jul 2016	$152.17M	+2.6%
Apr 2016	$148.31M	+12.1%
Jan 2016	$132.25M	+66.9%
Oct 2015	$79.25M	-45.9%
Jul 2015	$146.42M	+13.6%
Apr 2015	$128.90M	-1.4%
Jan 2015	$130.69M	+59.5%
Oct 2014	$81.95M	-36.5%
Jul 2014	$129.07M	+7.0%
Apr 2014	$120.67M	+6.8%
Jan 2014	$113.02M	-1.6%
Oct 2013	$114.87M	-7.9%
Jul 2013	$124.73M	+10.9%
Apr 2013	$112.42M	+12.0%
Jan 2013	$100.35M	-9.4%
Oct 2012	$110.70M	+1.5%
Jul 2012	$109.08M	+18.3%
Apr 2012	$92.19M	+5.3%
Jan 2012	$87.54M	+20.9%
Oct 2011	$72.43M	+11.1%
Jul 2011	$65.21M	-22.2%
Apr 2011	$83.77M	+14.3%
Jan 2011	$73.31M	-13.4%
Oct 2010	$84.62M	+12.1%
Jul 2010	$75.50M	+14.4%
Apr 2010	$65.97M	+5.6%
Jan 2010	$62.45M	+30.7%
Oct 2009	$47.78M	-15.2%
Jul 2009	$56.37M	-15.1%
Apr 2009	$66.39M	+17.4%
Jan 2009	$56.56M	-16.0%
Oct 2008	$67.30M	+28.7%
Jul 2008	$52.31M	+5.7%
Apr 2008	$49.48M	+23.5%
Jan 2008	$40.06M	-34.9%
Oct 2007	$61.54M	-17.6%
Jul 2007	$74.64M	+85.7%
Apr 2007	$40.20M	+19.3%
Jan 2007	$33.69M	-17.4%
Oct 2006	$40.78M	-25.8%
Jul 2006	$54.97M	+35.9%
Apr 2006	$40.44M	-22.9%
Jan 2006	$52.48M	+15.3%
Oct 2005	$45.53M	-23.9%
Jul 2005	$59.85M	+7.4%
Apr 2005	$55.74M	+54.9%

Month	Value	Change
Jan 2005	$35.99M	+9.0%
Oct 2004	$33.03M	+2.3%
Jul 2004	$32.30M	+1.7%
Apr 2004	$31.76M	+11.7%
Jan 2004	$28.44M	-3.1%
Oct 2003	$29.34M	+3.0%
Jul 2003	$28.47M	+18.0%
Apr 2003	$24.13M	+5.9%
Jan 2003	$22.79M	-9.1%
Oct 2002	$25.08M	+23.4%
Jul 2002	$20.33M	+14.6%
Apr 2002	$17.74M	+16.7%
Jan 2002	$15.20M	-26.0%
Oct 2001	$20.54M	+22.0%
Jul 2001	$16.84M	+4.2%
Apr 2001	$16.16M	+32.5%
Jan 2001	$12.20M	-26.2%
Oct 2000	$16.54M	-4.7%
Jul 2000	$17.35M	+38.9%
Apr 2000	$12.49M	+35.4%
Jan 2000	$9.22M	-48.7%
Oct 1999	$17.96M	+51.6%
Jul 1999	$11.85M	+12.0%
Apr 1999	$10.58M	+54.2%
Jan 1999	$6.86M	-29.9%
Oct 1998	$9.79M	-20.1%
Jul 1998	$12.26M	+16.5%
Apr 1998	$10.52M	+57.7%
Jan 1998	$6.67M	+30.9%
Oct 1997	$5.10M	-34.6%
Jul 1997	$7.80M	+16.4%
Apr 1997	$6.70M	+52.3%
Jan 1997	$4.40M	-21.4%
Oct 1996	$5.60M	-3.4%
Jul 1996	$5.80M	+34.9%
Apr 1996	$4.30M	+126.3%
Jan 1996	$1.90M	-64.2%
Oct 1995	$5.30M	+65.6%
Jul 1995	$3.20M	+88.2%
Apr 1995	$1.70M	+41.7%
Jan 1995	$1.20M	+300.0%
Oct 1994	-$600.00K	-150.0%
Jul 1994	$1.20M	+500.0%
Apr 1994	-$300.00K	+80.0%
Jan 1994	-$1.50M	0.0%
Oct 1993	-$1.50M	+87.8%
Jul 1993	-$12.30M	-156.3%
Apr 1993	-$4.80M	-4.3%
Jan 1993	-$4.60M	-2,200.0%
Oct 1992	-$200.00K	+98.4%
Jul 1992	-$12.50M	-303.2%
Apr 1992	-$3.10M	+16.2%
Jan 1992	-$3.70M	+47.9%
Oct 1991	-$7.10M	+7.8%
Jul 1991	-$7.70M	+3.8%
Apr 1991	-$8.00M	-23.1%
Jan 1991	-$6.50M	+86.5%
Oct 1990	-$48.20M	-519.1%
Jul 1990	$11.50M	-12.9%
Apr 1990	$13.20M	+28.2%
Jan 1990	$10.30M	+119.1%
Oct 1989	-$54.00M	-604.7%
Jul 1989	$10.70M	-25.7%
Apr 1989	$14.40M	+0.7%
Jan 1989	$14.30M	+103.3%
Oct 1988	-$428.30M	-409.7%
Jul 1988	$138.30M	-9.8%
Apr 1988	$153.30M	-3.9%
Jan 1988	$159.60M	+142.5%
Oct 1987	-$375.30M	-319.3%
Jul 1987	$171.10M	+43.5%
Apr 1987	$119.20M	+27.2%
Jan 1987	$93.70M	+133.2%
Oct 1986	-$282.60M	-315.6%
Jul 1986	$131.10M	+26.2%
Apr 1986	$103.90M	+21.7%
Jan 1986	$85.40M	+147.1%
Oct 1985	-$181.20M	-302.2%
Jul 1985	$89.60M	+19.8%
Apr 1985	$74.80M	+11.5%
Jan 1985	$67.10M	+144.7%
Oct 1984	-$150.10M	-321.7%
Jul 1984	$67.70M	+10.6%
Apr 1984	$61.20M	+7.2%
Jan 1984	$57.10M	-

FAQ

What is the current quarterly EBITDA of COO?: As of today, COO quarterly EBITDA is $317.00M
What is COO quarterly EBITDA most recent change?: COO quarterly EBITDA was down -5.65% on July 31, 2026
What is 1-year change in COO quarterly EBITDA?: COO quarterly EBITDA is up +16.93% year-over-year
How far is COO quarterly EBITDA from its all-time high?: COO quarterly EBITDA is currently -5.65% below its historical high of $336.00M set on April 30, 2026
How does COO quarterly EBITDA rank versus sector peers?: COO quarterly EBITDA is higher than 93.18% of companies in Healthcare sector
When is COO next earnings release?: The next earnings release for COO is on December 10, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.20B$45.90M+3.98%

July 31, 2026

Summary

Current Value: As of today, COO TTM EBITDA is $1.20B, up +3.98% on July 31, 2026
Historical Performance: COO TTM EBITDA is up +8.03% year-over-year, up +32.48% over the past 3 years
All-Time High Comparison: COO TTM EBITDA is currently at its all-time high
3-Year Low Comparison: COO TTM EBITDA is +32.48% above its 3-year low of $905.90M reached on an earlier date
Sector Comparison: COO TTM EBITDA is higher than 93.46% of companies in Healthcare sector

Performance

COO Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jul 31, 26	$1.20B	+4.0%	+8.0%	+32.5%	+30.1%
Annual EBITDA	Oct 31, 25	$1.11B	–	-1.2%	+19.0%	+68.2%
Quarterly EBITDA	Jul 31, 26	$317.00M	-5.7%	+16.9%	+28.8%	+21.0%
Price	Sep 29, 26	$56.63	-20.7%	-16.3%	-28.8%	-46.4%
PE Ratio	Sep 29, 26	19.33	-67.9%	-42.0%	-66.4%	+168.5%
TTM Revenue	Jul 31, 26	$4.24B	+0.1%	+4.7%	+20.6%	+48.9%
TTM EPS	Jul 31, 26	$2.93	+147.5%	+44.3%	+111.8%	-80.0%
	Jul 31, 26	$816.20M	+6.1%	+10.2%	+60.1%	+66.1%
TTM Net Income	Jul 31, 26	$570.30M	+141.9%	+39.9%	+107.2%	-80.4%

TTM EBITDA Highs

COO TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.20B	Jul 31, 26	at high
3Y	$1.20B	Jul 31, 26	at high
5Y	$1.20B	Jul 31, 26	at high
All	$1.20B	Jul 31, 26	at high

TTM EBITDA Lows

COO TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.06B	Oct 31, 25	+13.2%
3Y	$905.90M	N/A	+32.5%
5Y	$882.40M	Apr 30, 23	+36.0%
All	-$388.90M	Jul 31, 89	+408.6%

TTM EBITDA History

Month	Value	Change
Jul 2026	$1.20B	+4.0%
Apr 2026	$1.15B	+5.3%
Jan 2026	$1.10B	+3.3%
Oct 2025	$1.06B	-4.6%
Jul 2025	$1.11B	-0.9%
Apr 2025	$1.12B	+1.6%
Jan 2025	$1.10B	+2.1%
Oct 2024	$1.08B	+2.0%
Jul 2024	$1.06B	+3.5%
Apr 2024	$1.02B	+7.7%
Jan 2024	$951.50M	+1.1%
Oct 2023	$940.80M	+3.9%
Jul 2023	$905.90M	+2.7%
Apr 2023	$882.40M	-5.7%
Jan 2023	$935.30M	+1.5%
Oct 2022	$921.20M	+1.8%
Jul 2022	$905.10M	-4.2%
Apr 2022	$944.40M	-2.8%
Jan 2022	$971.90M	+1.3%
Oct 2021	$959.30M	+4.0%
Jul 2021	$922.30M	+13.7%
Apr 2021	$811.20M	+22.4%
Jan 2021	$662.50M	+2.8%
Oct 2020	$644.20M	-6.7%
Jul 2020	$690.80M	-9.2%
Apr 2020	$760.50M	-10.6%
Jan 2020	$850.50M	-0.1%
Oct 2019	$851.00M	+2.5%
Jul 2019	$830.40M	+2.2%
Apr 2019	$812.30M	+2.6%
Jan 2019	$791.40M	+2.4%
Oct 2018	$772.90M	+4.8%
Jul 2018	$737.80M	+4.4%
Apr 2018	$706.70M	+1.1%
Jan 2018	$699.00M	+4.8%
Oct 2017	$667.00M	+8.1%
Jul 2017	$617.23M	+3.2%
Apr 2017	$598.09M	+5.6%
Jan 2017	$566.20M	+2.2%
Oct 2016	$554.25M	+8.3%
Jul 2016	$511.98M	+1.1%
Apr 2016	$506.23M	+4.0%
Jan 2016	$486.83M	+0.3%
Oct 2015	$485.27M	-0.6%
Jul 2015	$487.97M	+3.7%
Apr 2015	$470.61M	+1.8%
Jan 2015	$462.38M	+4.0%
Oct 2014	$444.71M	-6.9%
Jul 2014	$477.63M	+0.9%
Apr 2014	$473.28M	+1.8%
Jan 2014	$465.03M	+2.8%
Oct 2013	$452.36M	+0.9%
Jul 2013	$448.19M	+3.6%
Apr 2013	$432.54M	+4.9%
Jan 2013	$412.31M	+3.2%
Oct 2012	$399.51M	+10.6%
Jul 2012	$361.24M	+13.8%
Apr 2012	$317.38M	+2.7%
Jan 2012	$308.95M	+4.8%
Oct 2011	$294.72M	-4.0%
Jul 2011	$306.91M	-3.2%
Apr 2011	$317.19M	+5.9%
Jan 2011	$299.40M	+3.8%
Oct 2010	$288.54M	+14.6%
Jul 2010	$251.70M	+8.2%
Apr 2010	$232.58M	-0.2%
Jan 2010	$233.00M	+2.6%
Oct 2009	$227.11M	-7.9%
Jul 2009	$246.62M	+1.7%
Apr 2009	$242.56M	+7.5%
Jan 2009	$225.65M	+7.9%
Oct 2008	$209.15M	+2.8%
Jul 2008	$203.39M	-9.9%
Apr 2008	$225.73M	+4.3%
Jan 2008	$216.45M	+3.0%
Oct 2007	$210.08M	+11.0%
Jul 2007	$189.32M	+11.6%
Apr 2007	$169.65M	-0.1%
Jan 2007	$169.89M	-10.0%
Oct 2006	$188.68M	-2.5%
Jul 2006	$193.42M	-2.5%
Apr 2006	$198.30M	-7.2%
Jan 2006	$213.59M	+8.4%
Oct 2005	$197.10M	+6.8%
Jul 2005	$184.60M	+17.5%
Apr 2005	$157.05M	+18.0%

Month	Value	Change
Jan 2005	$133.07M	+6.0%
Oct 2004	$125.52M	+3.0%
Jul 2004	$121.83M	+3.2%
Apr 2004	$118.01M	+6.9%
Jan 2004	$110.37M	+5.4%
Oct 2003	$104.73M	+4.2%
Jul 2003	$100.47M	+8.8%
Apr 2003	$92.32M	+7.4%
Jan 2003	$85.93M	+9.7%
Oct 2002	$78.34M	+6.1%
Jul 2002	$73.80M	+5.0%
Apr 2002	$70.32M	+2.3%
Jan 2002	$68.75M	+4.6%
Oct 2001	$65.75M	+6.5%
Jul 2001	$61.75M	-0.8%
Apr 2001	$62.26M	+6.3%
Jan 2001	$58.58M	+5.4%
Oct 2000	$55.60M	-2.5%
Jul 2000	$57.02M	+10.7%
Apr 2000	$51.52M	+3.8%
Jan 2000	$49.61M	+5.0%
Oct 1999	$47.25M	+20.9%
Jul 1999	$39.08M	-1.0%
Apr 1999	$39.49M	+0.1%
Jan 1999	$39.43M	+0.5%
Oct 1998	$39.25M	+13.6%
Jul 1998	$34.55M	+14.8%
Apr 1998	$30.10M	+14.6%
Jan 1998	$26.27M	+9.5%
Oct 1997	$24.00M	-2.0%
Jul 1997	$24.50M	+8.9%
Apr 1997	$22.50M	+11.9%
Jan 1997	$20.10M	+14.2%
Oct 1996	$17.60M	+1.7%
Jul 1996	$17.30M	+17.7%
Apr 1996	$14.70M	+21.5%
Jan 1996	$12.10M	+6.1%
Oct 1995	$11.40M	+107.3%
Jul 1995	$5.50M	+57.1%
Apr 1995	$3.50M	+133.3%
Jan 1995	$1.50M	+225.0%
Oct 1994	-$1.20M	+42.9%
Jul 1994	-$2.10M	+86.5%
Apr 1994	-$15.60M	+22.4%
Jan 1994	-$20.10M	+13.4%
Oct 1993	-$23.20M	-5.9%
Jul 1993	-$21.90M	+0.9%
Apr 1993	-$22.10M	-8.3%
Jan 1993	-$20.40M	-4.6%
Oct 1992	-$19.50M	+26.1%
Jul 1992	-$26.40M	-22.2%
Apr 1992	-$21.60M	+18.5%
Jan 1992	-$26.50M	+9.6%
Oct 1991	-$29.30M	+58.4%
Jul 1991	-$70.40M	-37.5%
Apr 1991	-$51.20M	-70.7%
Jan 1991	-$30.00M	-127.3%
Oct 1990	-$13.20M	+30.5%
Jul 1990	-$19.00M	+4.0%
Apr 1990	-$19.80M	-6.5%
Jan 1990	-$18.60M	-27.4%
Oct 1989	-$14.60M	+96.2%
Jul 1989	-$388.90M	-48.8%
Apr 1989	-$261.30M	-113.5%
Jan 1989	-$122.40M	-634.5%
Oct 1988	$22.90M	-69.8%
Jul 1988	$75.90M	-30.2%
Apr 1988	$108.70M	+45.7%
Jan 1988	$74.60M	+757.5%
Oct 1987	$8.70M	-91.4%
Jul 1987	$101.40M	+65.1%
Apr 1987	$61.40M	+33.2%
Jan 1987	$46.10M	+22.0%
Oct 1986	$37.80M	-72.8%
Jul 1986	$139.20M	+42.5%
Apr 1986	$97.70M	+42.4%
Jan 1986	$68.60M	+36.4%
Oct 1985	$50.30M	-38.2%
Jul 1985	$81.40M	+36.8%
Apr 1985	$59.50M	+29.6%
Jan 1985	$45.90M	+27.9%
Oct 1984	$35.90M	-80.7%
Jul 1984	$186.00M	+57.2%
Apr 1984	$118.30M	+107.2%
Jan 1984	$57.10M	-

FAQ

What is the current TTM EBITDA of COO?: As of today, COO TTM EBITDA is $1.20B
What is COO TTM EBITDA most recent change?: COO TTM EBITDA was up +3.98% on July 31, 2026
What is 1-year change in COO TTM EBITDA?: COO TTM EBITDA is up +8.03% year-over-year
How far is COO TTM EBITDA from its all-time high?: COO TTM EBITDA is currently at its all-time high
How does COO TTM EBITDA rank versus sector peers?: COO TTM EBITDA is higher than 93.46% of companies in Healthcare sector
When is COO next earnings release?: The next earnings release for COO is on December 10, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

COO Official Website www.coopercos.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/711404/000162828025055615/0001628280-25-055615-index.htm
COO Profile on Yahoo Finance finance.yahoo.com/quote/COO
COO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coo